111 related articles for article (PubMed ID: 28062059)
41. Dietary fats and coronary heart disease.
Willett WC
J Intern Med; 2012 Jul; 272(1):13-24. PubMed ID: 22583051
[TBL] [Abstract][Full Text] [Related]
42. Omega-3: the vanishing nutrient beyond cardiovascular prevention and treatment.
Endevelt R; Shahar DR
Isr Med Assoc J; 2004 Apr; 6(4):235-9. PubMed ID: 15115264
[TBL] [Abstract][Full Text] [Related]
43. Marine n-3 polyunsaturated fatty acids and coronary heart disease: Part II. clinical trials and recommendations.
Schmidt EB; Arnesen H; Christensen JH; Rasmussen LH; Kristensen SD; De Caterina R
Thromb Res; 2005; 115(4):257-62. PubMed ID: 15668184
[No Abstract] [Full Text] [Related]
44. Some effects of omega 3 fatty acids on coronary heart disease.
Leaf A
World Rev Nutr Diet; 1994; 76():1-8. PubMed ID: 7856216
[No Abstract] [Full Text] [Related]
45. Another Nail in the Coffin for Fish Oil Supplements.
Abbasi J
JAMA; 2018 May; 319(18):1851-1852. PubMed ID: 29710294
[No Abstract] [Full Text] [Related]
46. Effects of omega-3 fatty acid for sudden cardiac death prevention in patients with cardiovascular disease: a contemporary meta-analysis of randomized, controlled trials.
Chen Q; Cheng LQ; Xiao TH; Zhang YX; Zhu M; Zhang R; Li K; Wang Y; Li Y
Cardiovasc Drugs Ther; 2011 Jun; 25(3):259-65. PubMed ID: 21626218
[TBL] [Abstract][Full Text] [Related]
47. n-3 Fatty acids, cardiac arrhythmia and fatal coronary heart disease.
Brouwer IA; Geelen A; Katan MB
Prog Lipid Res; 2006 Jul; 45(4):357-67. PubMed ID: 16678270
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of omega-3 fatty acid supplementation in primary and secondary prevention of coronary heart disease.
Weisman D; Motro M; Schwammenthal E; Fisman EZ; Tenenbaum A; Tanne D; Adler Y
Isr Med Assoc J; 2004 Apr; 6(4):227-32. PubMed ID: 15115262
[No Abstract] [Full Text] [Related]
49. [N-3 polyunsaturated fatty acids (EPA)].
Oki M; Sata M
Nihon Rinsho; 2011 Sep; 69 Suppl 7():425-9. PubMed ID: 22519027
[No Abstract] [Full Text] [Related]
50. The role of omega-3 fatty acids in primary prevention of coronary artery disease and in atrial fibrillation is controversial.
Saravanan P; Davidson NC
J Am Coll Cardiol; 2010 Jan; 55(4):410-1; author reply 411-2. PubMed ID: 20117448
[No Abstract] [Full Text] [Related]
51. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications.
Bays HE; Tighe AP; Sadovsky R; Davidson MH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998
[TBL] [Abstract][Full Text] [Related]
52. The epidemiology of omega 3 fatty acids.
Dyerberg J
World Rev Nutr Diet; 1994; 76():133-6. PubMed ID: 7856223
[No Abstract] [Full Text] [Related]
53. Marine n-3 fatty acids and thrombosis.
Schmidt EB
Thromb Res; 2003; 111(1-2):9-10. PubMed ID: 14644072
[No Abstract] [Full Text] [Related]
54. A Medical Fish Story.
Br J Ophthalmol; 1953 Sep; 37(9):569-72. PubMed ID: 18170581
[No Abstract] [Full Text] [Related]
55. A fish story.
Nat Biotechnol; 2000 Jan; 18(1):11. PubMed ID: 10625369
[No Abstract] [Full Text] [Related]
56. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
57. A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease Risk.
Alexander DD; Miller PE; Van Elswyk ME; Kuratko CN; Bylsma LC
Mayo Clin Proc; 2017 Jan; 92(1):15-29. PubMed ID: 28062061
[TBL] [Abstract][Full Text] [Related]
58. An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health.
Elagizi A; Lavie CJ; O'Keefe E; Marshall K; O'Keefe JH; Milani RV
Nutrients; 2021 Jan; 13(1):. PubMed ID: 33445534
[TBL] [Abstract][Full Text] [Related]
59. Potential Benefits of Omega-3 Polyunsaturated Fatty Acids (N3PUFAs) on Cardiovascular Health Associated with COVID-19: An Update for 2023.
Lu LW; Quek SY; Lu SP; Chen JH
Metabolites; 2023 May; 13(5):. PubMed ID: 37233671
[TBL] [Abstract][Full Text] [Related]
60. Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials.
Shen S; Gong C; Jin K; Zhou L; Xiao Y; Ma L
Front Nutr; 2022; 9():809311. PubMed ID: 35187035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
